Verona Pharma PLC (VRNA)
37.86
-0.99
(-2.55%)
USD |
NASDAQ |
Nov 21, 16:00
37.93
+0.07
(+0.18%)
After-Hours: 20:00
Verona Pharma Debt to Equity Ratio: 0.9197 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.9197 |
| June 30, 2024 | 0.7113 |
| March 31, 2024 | 0.2158 |
| December 31, 2023 | 0.1941 |
| September 30, 2023 | 0.0755 |
| June 30, 2023 | 0.0727 |
| March 31, 2023 | 0.0716 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0424 |
| September 30, 2022 | 0.0212 |
| June 30, 2022 | 0.0449 |
| March 31, 2022 | 0.039 |
| December 31, 2021 | 0.0329 |
| September 30, 2021 | 0.0287 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0212
Minimum
Sep 2022
0.9197
Maximum
Sep 2024
0.19
Average
0.0716
Median
Mar 2023
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 381.82M |
| Total Liabilities (Quarterly) | 251.33M |
| Shareholders Equity (Quarterly) | 130.49M |
| Current Ratio | 13.03 |
| Net Debt Paydown Yield | -0.85% |